Molecular-biological analysis of the effect of methamphetamine on the heart in restrained mice

Legal Medicine

Volumn 12, Issue 2, 2010, Pages 79-83

  Shinone, Kotaro ^a   Tomita, Masafumi ^b   Inoue, Hiromasa ^a   Nakagawa, Yasuhisa ^a   Ikemura, Mayumi ^a   Nata, Masayuki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Cytokine; Hypertension; Methamphetamine; Myocardial damage; Restraint; Sudden death

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; METHAMPHETAMINE; RGS2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CYTOKINE PRODUCTION; GENE EXPRESSION; HEART DEATH; HEART MUSCLE; HYPERTENSION; IMMOBILIZATION STRESS; INFLAMMATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUDDEN DEATH;

ANIMALS; CYTOKINES; DEATH, SUDDEN, CARDIAC; FORENSIC PATHOLOGY; GENE EXPRESSION; HEART; HYPERTENSION; MALE; METHAMPHETAMINE; MICE; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; MYOCARDIUM; RESTRAINT, PHYSICAL; RNA, MESSENGER;

EID: 76849091107     PISSN: 13446223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.legalmed.2010.01.001     Document Type: Article

References (37)

1. Kaye S., McKetin R., Duflou J., and Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 102 (2007) 1204-1211
2. Yamamoto J. Recent trends of drug abuse in Japan. Ann NY Acad Sci 1025 (2004) 430-438
3. Inoue H., Ikeda N., Kudo K., Ishida T., Terada M., and Matoba R. Methamphetamine-related sudden death with a concentration which was of a 'toxic level'. Leg Med 8 (2006) 150-155
4. Albertson T.E., Derlet R.W., and Van Hoozen B.E. Methamphetamine and the expanding complications of amphetamines. West J Med 170 (1999) 214-219
5. Kalant H., and Kalant O.J. Death in amphetamine users: causes and rates. CMA J 112 (1975) 299-304
6. Stratton S.J., Rogers C., Brickett K., and Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med 19 3 (2001) 187-191
7. Yu Q., Larson D.F., and Watson R.R. Heart disease, methamphetamine and AIDS. Life Sci 73 (2003) 129-140
8. Maeno Y., Iwasa M., Inoue H., Koyama H., and Matoba R. Methamphetamine induces an increase in cell size and reorganization of myofibrils in cultured adult rat cardiomyocytes. Int J Legal Med 113 (2000) 201-207
9. Maeno Y., Iwasa M., Inoue H., Koyama H., Matoba R., and Nagao M. Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes. Forensic Sci Int 113 (2000) 239-243
10. Berankova K., Habrdova V., Balikova M., and Strejc P. Methamphetamine in hair and interpretation of forensic findings in a fatal case. Forensic Sci Int 153 (2005) 93-97
11. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmi H., Hoshino K., et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430 (2004) 218-222
12. Matsuo S., Yamazaki S., Takeshige K., and Muta T. Crucial roles of binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activation. Biochem J 405 (2007) 605-615
13. Bonta P.I., Pols T.W., and de Vries C.J. NR4A nuclear receptors in atherosclerosis and vein-graft disease. Trends Cardiovasc Med 17 (2007) 105-111
14. Harant H., and Lindley I.J. Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB. Nucleic Acids Res 32 17 (2004) 5280-5290
15. Wang T., Zhang X., and Li J.J. The role of NF-κB in the regulation of cell stress responses. Int Immunopharmacol 2 (2002) 1509-1520
16. Rahman I. Regulation of nuclear factor-κB, activator protein-1, and glutathione levels by tumor necrosis factor- and dexamethasone in alveolar epithelial cells. Biochem Pharmacol 60 (2000) 1041-1049
17. Nukina H., Sudo N., Aiba Y., Oyama N., Koga Y., and Kubo C. Restraint stress elevates the plasma interleukin-6 levels in germ-free mice. J Neuroimmunol 115 (2001) 46-52
18. Scheuer D.A., and Mifflin S.W. Repeated intermittent stress exacerbates myocardial ischemia-reperfusion injury. Am J Physiol Regulatory Integrative Comp Physiol 274 (1998) 470-475
19. Zhao Y., Wang W., and Qian L. Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis. Cell Stress Chaperones 12 (2007) 83-95
20. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94 (2004) 1543-1553
21. Matsumori A., and Sasayama S. The role of inflammatory mediators in the failing heart: immunomodulation of cytokines in experimental models of heart failure. Heart Fail Rev 6 (2001) 129-136
22. Knuefermann P., Vallejo J., and Mann D.L. The role of innate immune responses in the heart in health and disease. Trends Cardiovasc Med 14 (2004) 1-7
23. Wilson E.M., Diwan A., Spinale F.G., and Mann D.L. Duality of innate stress responses in cardiac injury, repair, and remodeling. J Mol Cell Cardiol 37 4 (2004) 801-811
24. Wang X., and Liu Y. Regulation of innate immune response by MAP kinase phosphatase-1. Cellular Signaling 19 (2007) 1372-1382
25. Salojin K.V., Owusu I.B., Millerchip K.A., Potter M., Platt K.A., and Oravecz T. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 176 (2006) 1899-1907
26. Lang R., Hammer M., and Mages J. DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 177 (2006) 7497-7504
27. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., et al. Dynamic regulation of pro- and anti-inflammatory cytokineses by MAPK phosphatase 1 in innate immune responses. Proc Natl Acad Sci USA 103 7 (2006) 2274-2279
28. Klamp T., Boehm U., Schenk D., Pfeffer K., and Howard J.H. A giant GTPase, very large inducible GTPase-1, is inducible by IFNs. J Immunol 171 (2003) 1255-1265
29. Le T.H., and Coffman T.M. Rgs2: a "turn-off" in hypertension. J Clin Invest 111 (2003) 441-443
30. Grant S.L., Lassègue B., Griendling K.K., Ushio-Fukai M., Lyons P.R., and Alexander R.W. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Mol Pharmacol 57 3 (2000) 460-467
31. Heximer S.P., Knutsen R.H., Sun X., Kaltenbronn K.M., Rhee M.H., Peng N., et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 111 (2003) 445-452
32. Tang M., Wang G., Lu P., Karas R.H., Aronovitz M., Heximer S.P., et al. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9 12 (2003) 1506-1512
33. Holycross B.J., and Radin M.J. Cytokines I heart failure: potential interactions with angiotensin II and leptin. Mol Interv 2 (2002) 424-427
34. Sekiguchi K., Li X., Coker M., Flesch M., Barger P.M., Sivasubramanian N., et al. Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure. Cardiovasc Res 63 (2004) 433-442
35. Blumer J.B., Smrcka A.V., and Lanier S.M. Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. Pharmacol Ther 113 3 (2007) 488-506
36. Massrieh W., Derjuga A., Doualla-Bell F., Ku C.Y., Sanborn B.M., and Blank V. Regulation of the MAFF transcription factor by proinflammatory cytokines in myometrial cells. Biol Reprod 74 4 (2006) 699-705
37. Blank V. Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?. J Mol Biol 376 4 (2008) 913-925